CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 160 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $638,106 | -15.9% | 23,187 | +3.7% | 0.00% | -20.0% |
| Q2 2023 | $758,777 | -4.7% | 22,363 | +1.1% | 0.01% | 0.0% |
| Q1 2023 | $795,806 | -17.6% | 22,118 | +2.0% | 0.01% | -28.6% |
| Q4 2022 | $966,144 | +57.9% | 21,677 | -0.4% | 0.01% | +75.0% |
| Q3 2022 | $612,000 | +5.9% | 21,756 | +1.4% | 0.00% | 0.0% |
| Q2 2022 | $578,000 | -25.7% | 21,449 | -6.1% | 0.00% | 0.0% |
| Q1 2022 | $778,000 | -17.6% | 22,831 | -6.6% | 0.00% | -20.0% |
| Q4 2021 | $944,000 | -30.5% | 24,438 | -2.9% | 0.01% | -28.6% |
| Q3 2021 | $1,359,000 | +84.9% | 25,169 | +14.6% | 0.01% | +250.0% |
| Q2 2021 | $735,000 | – | 21,970 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 1,017,524 | $20,961,000 | 7.56% |
| Octagon Capital Advisors LP | 561,398 | $11,565,000 | 4.36% |
| COMMODORE CAPITAL LP | 369,951 | $7,621,000 | 3.04% |
| Opaleye Management Inc. | 985,000 | $20,291,000 | 2.98% |
| VR Adviser, LLC | 1,240,610 | $25,557,000 | 2.77% |
| TSP Capital Management Group, LLC | 359,229 | $7,400,000 | 2.61% |
| RTW INVESTMENTS, LP | 3,908,947 | $80,524,000 | 1.26% |
| Ghost Tree Capital, LLC | 250,000 | $5,150,000 | 1.21% |
| Tri Locum Partners LP | 196,672 | $4,051,000 | 1.00% |
| Redmile Group, LLC | 3,387,788 | $69,788,000 | 0.98% |